PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-7.52%
Both yoy net incomes decline, with MRVL at -22.76%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
1.02%
Some D&A expansion while MRVL is negative at -30.89%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-133.25%
Negative yoy deferred tax while MRVL stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
2742.05%
SBC growth of 2742.05% while MRVL is zero at 0.00%. Bruce Berkowitz would see some additional share issuance that must be justified by expansions or retention needs.
-203.72%
Both reduce yoy usage, with MRVL at -911.21%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
9.47%
AR growth of 9.47% while MRVL is zero at 0.00%. Bruce Berkowitz would see a mild difference in credit approach that could matter for cash flow.
-392.66%
Negative yoy inventory while MRVL is 122.16%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
4015.99%
AP growth of 4015.99% while MRVL is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might matter for short-term liquidity if expansions are large.
-176.67%
Both reduce yoy usage, with MRVL at -493.97%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-29.49%
Negative yoy while MRVL is 1119.78%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-77.64%
Both yoy CFO lines are negative, with MRVL at -66.26%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
11.85%
CapEx growth well above MRVL's 22.16%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
-452.52%
Negative yoy acquisition while MRVL stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
40.63%
Purchases well above MRVL's 74.15%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
-87.51%
We reduce yoy sales while MRVL is 144.51%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-452.52%
We reduce yoy other investing while MRVL is 100.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-1371.68%
We reduce yoy invests while MRVL stands at 136.55%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
288.99%
We slightly raise equity while MRVL is negative at -88.80%. John Neff sees competitor possibly preserving share count or buying back shares.
No Data
No Data available this quarter, please select a different quarter.